Clinical trial
The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating Glomerular Filtration Rate and Predicting Residual Renal Function After Partial Nephrectomy
NCT06973798 is registered in ClinicalTrials.gov with Luo Yaping as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating Glomerular Filtration Rate and Predicting Residual Renal Function After Partial Nephrectomy
- Lead sponsor
- Luo Yaping
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2025
- Completion date
- November 10, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glomerular filtration rate, kidney neoplasms / surgery, positron-emission tomography(pet)